Benefits of Treating Arteriovenous Malformations in Hereditary Hemorrhagic Telangiectasia: A Retrospective Analysis of 14 Patients

BACKGROUND: Arteriovenous malformations (AVMs) are a cardinal feature of hereditary hemorrhagic telangiectasia (HHT). However, whether to treat brain AVMs in patients with HHT remains questionable because of the possible risks. METHODS: We performed a retrospective study of patients with HHT who had...

Descripción completa

Detalles Bibliográficos
Autores principales: Woodall, M. Neil, Nakaji, Peter, Spetzler, Robert F.
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Elsevier 2019
Materias:
Original Article
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6584483/
https://www.ncbi.nlm.nih.gov/pubmed/31225521
http://dx.doi.org/10.1016/j.wnsx.2019.100029

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6584483/
https://www.ncbi.nlm.nih.gov/pubmed/31225521
http://dx.doi.org/10.1016/j.wnsx.2019.100029

Ejemplares similares